DOUGLAS B GIVEN Insider Trading $ARWR ARROWHEAD PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DOUGLAS B GIVEN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DOUGLAS B GIVEN. DOUGLAS B GIVEN is Director in AKSYS LTD ($AKSY) and Director in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR).

DOUGLAS B GIVEN in ARROWHEAD PHARMACEUTICALS, INC.

Trading Symbol: ARWR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOUGLAS B GIVEN: Director
Holdings: 114,868 shares
Current Value: $225,141
Latest Transaction: Jun 24 2021
$ARWR Market Capitalization: $149.83M
$ARWR Previous Close: $1.96

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DOUGLAS B GIVEN in ARROWHEAD PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AKSY, ARWR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 24 2021ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS89.214,500401,445114,868119.4 K to 114.9 K (-3.77 %)
Feb 24 2021ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS88.731,12599,82113,87515 K to 13.9 K (-7.50 %)
Jan 19 2021ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS83.283,000249,84012,50015.5 K to 12.5 K (-19.35 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.00350113,868113.9 K to 113.9 K (-0.03 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.00350113,903113.9 K to 113.9 K (-0.03 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.002000113,938114.1 K to 113.9 K (-0.18 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.00350114,138114.2 K to 114.1 K (-0.03 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.00350114,173114.2 K to 114.2 K (-0.03 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.002000114,208114.4 K to 114.2 K (-0.17 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.002000114,408114.6 K to 114.4 K (-0.17 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.00650114,608114.7 K to 114.6 K (-0.06 %)
Dec 29 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.00650114,673114.7 K to 114.7 K (-0.06 %)
Dec 18 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS79.5950039,79515,00015.5 K to 15 K (-3.23 %)
Dec 18 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS79.309,075719,648114,738123.8 K to 114.7 K (-7.33 %)
Dec 18 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.0015,500015,5000 to 15.5 K
Dec 18 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.0015,500015,5000 to 15.5 K
Dec 18 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.0031,0000123,813154.8 K to 123.8 K (-20.02 %)
Apr 16 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.001,1120154,813155.9 K to 154.8 K (-0.71 %)
Apr 16 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS36.8925,000922,250155,925180.9 K to 155.9 K (-13.82 %)
Apr 16 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.001,1120154,813155.9 K to 154.8 K (-0.71 %)
Apr 16 2020ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS36.8925,000922,250155,925180.9 K to 155.9 K (-13.82 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM4.757,00033,2500
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM2.6210,00026,2007,000
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM2.1918,00039,42017,000
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorOption ExerciseM5.1930,000155,70035,000
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS19.2565,0001,251,250175,130240.1 K to 175.1 K (-27.07 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM4.757,00033,250240,130233.1 K to 240.1 K (+3.00 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM2.6210,00026,200233,130223.1 K to 233.1 K (+4.48 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM2.1918,00039,420223,130205.1 K to 223.1 K (+8.77 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorBuyM5.1930,000155,700205,130175.1 K to 205.1 K (+17.13 %)
Feb 26 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS18.053,00054,150175,130178.1 K to 175.1 K (-1.68 %)
Jan 24 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS13.583,00040,740178,130181.1 K to 178.1 K (-1.66 %)
Jan 03 2019ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGrantA0.0036,0000181,130145.1 K to 181.1 K (+24.81 %)
Dec 28 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS12.003,00036,000145,130148.1 K to 145.1 K (-2.03 %)
Nov 26 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS12.743,00038,220148,130151.1 K to 148.1 K (-1.99 %)
Nov 26 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS12.743,00038,220148,130151.1 K to 148.1 K (-1.99 %)
Oct 23 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.003,8700151,130155 K to 151.1 K (-2.50 %)
Apr 25 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS6.6325,000165,750155,000180 K to 155 K (-13.89 %)
Jan 03 2018ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGrantA0.0030,0000180,000150 K to 180 K (+20.00 %)
Jan 04 2017ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGrantA0.0080,0000150,00070 K to 150 K (+114.29 %)
Oct 18 2016ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorSellS6.7212,00080,64070,00082 K to 70 K (-14.63 %)
Oct 18 2016ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGiftG0.008,000082,00090 K to 82 K (-8.89 %)
Jan 04 2016ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGrantA0.0035,000090,00055 K to 90 K (+63.64 %)
Mar 06 2015ARWRARROWHEAD PHARMACE ...GIVEN DOUGLAS BDirectorGrantA0.0035,000055,00020 K to 55 K (+175.00 %)

Page:   1